Tender For SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 4(Item No1051 TO 1400)

Sharing tender

SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 4(Item No1051 TO 1400)- dopamine hydrochloride injection 40 mg/ml, 5 ml oule, drotaverine 40 mg/2ml, each 1 ml contains: 215.2 mg of porcine brain derived peptide preparation(cerebrolysin concentrate ) in aqueous solution, each 100 ml contains: active constituents: l-ieucine 1.30 g, l-isoleucine 0.80 g, l -lysine acetate 1.20 g, l-iysine 0.851 g, l-methionine 0.312 g, l-phenylalanine 0.375 g, l-threonine 0.440 g, l-tryptophan 0.201 g, l-valine 0.900 g, l-arginine 0.750 g, l-histidine 0.476 g, glycine 0.415 g, taurine 0.040 g, l-serine 0.767 g, l-alanine 0.930 g, l-proline 0.971 g, n-acetyl-l-tyrosine 0.5176 g, l-tyrosine 0.420 g, n-acetyl-l-cysteine 0.070 g, l-cysteine 0,052 g, l-malic acid 0.262 g, water for injections q.s.total amino acids 100 g/l, total nitrogen content 14.9 g/l, theor.osmolarity 885 mosm/l, emicizumab 150 mg, emicizumab 30 mg, emicizumab 60 mg, enalapril 1.25 mg, enoxaparin sodium injection 60 mg/0.6 ml, pre filled syringe., ephedrine hcl injection 30 mg, epirubicin injection 50 mg, equine rabies immunoglobulin injection (erig) 300 iu/ ml (5 ml vial), ertapenem sodium for inj - 1gm, erythropoietin 5000 iu/ml, erythropoietin injection 4000 iu/ml, esmolol injection 10 mg/ml, eteophylline and theophylline injection (2 ml oule), ethamsylate 250mg, etomidate emulsion injection 2 mg/1 ml 10 ml vial/ oule, etoposide injection 100 mg, evolocumab recombinant (140mg/ml), faricimab, fast acting insulin aspart 100 iu/ml in 3ml pfs type of insulin:ultra short acting prandial, fat emulsion 20percentage w/v(pl/tg ratio 0.06)250 ml, fentanyl citrate injection 50 mcg/ml (2 ml oule) (for im/iv/transdermal use)., feracrylum 1 percentage w/v sterile solution, 100 ml bottle, ferric carboxy maltose injection 50 mg/ml , 10 ml vial. (for iv inj/infusion), ferric carboxy maltose injection 50 mg/ml, 20 ml vial (for iv injection/infusion), filgrastim 300 mcg, fluconazole 200 mg / 100 ml, flumazenil 0.5mg/5ml, fluphenazine decanoate 25 mg/ml, fondaparinux sodium 2.5mg/0.5ml, fosfomycin sodium 4gm, fosphenytoin 150mg per 2 ml, frusemide injection 10 mg/ml (for im/slow iv use) (2 ml oule), fulvestrant injection 250mg, gadobutrol 1 mmol, 5 ml bottle, gadodiamide 0.5 mmol / ml, ganciclovir 500 mg, gemcitabline injection 1 gm, gentamicin injection 80 mg (2 ml vial) (im/slow iv/iv infusion), glucagon 1 mg/ml, glutathione for inj 1200 mg inj with wf inj, glutathione for inj 2000 mg inj with wf inj, glyceryl trinitrate injection 5 mg/ml (nitroglycerine inj.) (5 ml oule), glycine irrigation 1.5percentage 3 litre, glycopegylated recombinant factor ix 1000 iu, glycopegylated recombinant factor ix 2000 iu, glycopegylated recombinant factor ix 500 iu, glycopegylated recombinant factor viii 1000 iu, glycopegylated recombinant factor viii 1500 iu, glycopegylated recombinant factor viii 2000 iu, glycopegylated recombinant factor viii 500 iu, glycopyrrolate injection 0.2 mg/ml , 1ml oule (im/iv use), granulocyte colony stimulating factor (gcsf) injection 300 mcg, haemocoagulase 1cu/ml, haloperidol injection 5 mg/ml (for im/iv use) (1 ml oule), hemoststic gelatin thrombin matrix 2500iu, heparin sodium injection 5000 units/ml (5 ml vial) (for iv/sc use), hepatitis b immunoglobulin human 100 iu, hepatitis b immunoglobulin human 200 iu, hepatitis- b vaccine 20 mcg/ml (r-dna) 10 ml vial, hepatitis b vaccine 20 mcg/ml (r-dna) 1ml / vial, human albumin 20 percentage(sterile for iv use) (50 ml bottle), human albumin injection 20percentage, 100 ml, human albumin solution i.p. 25percentage100ml, human albumin solution i.p. 5percentage250ml, human c1 esterase inhibitor 500iu e.p., human chronic gonadotropin normone 5000 iu, human growth hormone (somatropine) (15 iu to 18 iu ), human immunoglobulin for intravenous administration igm iga igg, human normal immunoglobulin & histamine dihydrochloride (histoglob), human normal immunoglobulin for iv use 2.5 gm. (iv/ig 2.5 gm), human normal immunoglobulin for iv use.(5 gm vial), human papillomavirus 9-valent vaccine- 0.5ml, hyaluronidase injection 1500 iu (lyophilized), hydrocortisone ip 25 mg, hydrocortisone ip 50 mg, hydrocortisone sodium succinate injection 100 mg, hydroxy ethyl starch 6percentagew/v (intravenous infusion), hydroxy propyl methyl cellulose 2percentagew/v, 5 ml vial, hyoscine butyl bromide injection 20 mg/ml, (1 ml oule), hypromellose opthalmic solution 2percentage(intavisc pf) (3000), idursulfase (r-dna origin) -2mg/ml, ifosfamide 1gm + mensa 200 mg/2ml, ifosfamide with 200 mg, imipenem 1 gm + cilastatin 1 gm, imipenem 500 mg, imipenem 500mg + cilastatin 500mg, immuno nutrition as immuno modulation as intravenous glutamine dipeptides 100 ml, influenza a(h1n1) vaccine, insulin (human) injection 40 i.u. / ml 50:50, insulin aspart 100 iu/ml, insulin degludec/insulin aspart (r-dna origin) (70percentagesoluble insulin degludec and 30percentagesoluble insulin aspart) 100 iu/ml in 3ml pfs type of insulin:co-formulation analogue, insulin human (70:30) highly purified human insulin 40 iu/ ml, insulin human injection, (monocomponent) 40 units/ml, 10 ml vial, insulin lispro 100 iu/ml, intracameral moxifloxacin 0.5 percentagew/v, intratracheal suspension bovine pulmonary surfuctant (4 ml vial), intratrachel pulmonary porcine pulmonary natural lung surfuctant 1.5 ml injection, intravenous fat emulsion with omega 3 fatty acids, highly refined fish oil 10 g , eicosapentaenoic acid (epa)1.25-2.82g, docosahexaenoic acid (dha) 1.44-3.09 g, alpha tocopherol as antioxidant., glycerol, purified egg phosphate, sodium oleate, sodium hydroxide., intravenous lignocaine 2percentage 50 ml, iohexol 350mg 100 ml, iohexol injection (50 ml bottle/vial) (for i.v.use), irinotecan 100 mg, iron sucrose injection, 5 ml oule, (for i.v. use), isobaric bupivacaine 0.5percentage 4 ml, isoprenaline 2mg/ml, isotonic balanced crystroilid solution withour calcium in self collapsable viaflo bag, isoxsuprine hcl, 5 mg/ml, 2 ml , ixekizumab 80mg, ketamine hcl 50 mg, (10 ml vial) (deep im/slow iv use), ketorolac (30mg), labetalol injection 5 mg/ml, (4 ml vial/ oule), lacosamide 100 mg/ ml, lacosamide 200 mg/ 20 ml, lactoferrin 100 mg+ferrous bisglycinate 200 mg+folic acid 400 mcg, leucovorin injection 10 mg/ml , (5 ml vial), leuprolide powder for injection (depot) 11.25 mg, leuprolide powder for injection (lyophilised) (depot) 3.75 mg, levetiracetam 500 mg, levobupivacaine hydrochloride 5 mg + dextrose ip 80 mg, levobupivacaine solution 5 mg / 1 ml, levofloxacin infusion 500 mg/100 ml (i.v. use), 100 ml bottle, levothyroxine 200 mcg/5ml, lignocaine hcl 20 mg and adrenaline bitartrate 0.01 mg injection (30 ml vial), lignocaine hydrochloride injection 2percentage w/v, (30 ml vial), lignocaine without preservative 2percentage, 20 mg/ml, 10 ml vial, linezolid 600mg 300ml in double sterlised within overwrap closed system bag with long temper evedent cap and self sealing port, linezolid infusion 200 mg/100 ml, (100 ml bottle), liothyronin 10mcg/ml, lipid emulsion 20percentage -250 ml, lipid emlusion 20percentage -500 ml, liposomal hotericin b 50 mg/vial, lorazepam 2 mg/ml, l-ornithine l-aspartate infusion, lyophilised altephase powder 20mg, lyophilised altephase powder 50mg, lyophilised polyvalent antisnake venom serum (snakevenom antiserum powder) (10 ml vial), magnesium sulphate 20 percent w/v injection (iv use), magnesium sulphate injection 50 percentage w/v (im use) (2 ml oule), manganese (as sulphate) usp 0.1 mg, zinc (as sulphate) ip 1 mg, selenium (as selenious acid) usp 20 mcg, chromium (as cloride) usp 4 mcg, cooper (as sulphate) usp 0.4 mg, benzyl alcohol ( as preservative) ip 0.9percentagew/v, mannitol injection 20percentage w/v (100 ml ffs bottle) (for iv infusion), marstacimab each prefilled pen contains marstacimab 150 mg/ml, meningococcal vaccine (group a, c, y & w-135) combined vaccine -1 dose of 0.5ml, mephentermine sulphate injection 15 mg (1 ml oule), meropenam-1 gm+edta-37.5 mg, meropenam-500 mg+edta-18.75 mg, meropenem 100gm+sulbactum 500mg+edta-37.5 mg, meropenem 1gm + tazobactum 125mg+edta-37.5, meropenem injection 500 mg, mesna injection 1000 mg, methocarbomol, methotrexate 10 mg, methotrexate injection 50 mg/2 ml, methyl ergometrine injection 0.2 mg/ml (1 ml oule) (for sc/im/iv use), methyl prednisolone sodium succinate 125 mg, methyl prednisolone sodium succinate 40 mg, methyl prednisolone sodium succinate for injection 500 mg (powder)(for slow iv infusion), methylene blue sterile for iv use/for transuterine (use 1percentage 10 ml ), metoclopramide hydrochloride injection 10 mg/2 ml (2 ml oule) (for im/iv use), metoprolol 1 mg/ ml, metronidazole injection 5 mg/ml (100 ml ffs bottle) (i.v.infusion), midazolam injection 1 mg/ml (5 ml vial) (for im/iv use), milrinone 1 mg/ml, morphine 10mg, 1ml, moxifloxacin 100 ml, moxifloxacin ophthalmic solution, multiple electrolyte and dextrose injection (type-3) (multiple electrolyte m), multiple electrolyte and dextrose injection type 1 (paediatric) (multiple electrolyte p), multivitamin injection (for iv use), 10 ml oule, n-acetyl cysteine 200 mg/ml, n-butyl cyanoacrylate injection, neostigmine methylsulphate 0.5 mg/ml (1 ml oule) (for sc/im/iv use), nepafenac micronized suspension 0.1percentage with stabilzed oxychloro complex ( purite) (bak free), new generation 3 chambered bag for parenteral nutrition (iv injection for central line) 1477 ml containing combination of smoflipid 20percentage; refined soyabean oil 16.9 g, medium chain triglycerides 16.9 g, refinded olive oil 14.1 g and fish oil rich in omega-3-acids 8.4 g as source of calories with 75 g amino acids,taurine, zinc, electolytes and 42percentage glucose solution with enviornment friendly bag material having t er evident arrows flaps providing 1600 total calories in 1477 ml -1300 non protein energy, new generation 3 chambered bag for parenteral nutrition (iv injection for central line) 1970 ml containing combination of smoflipid 20percentage; refined soyabean oil 22.5 g, medium chain triglycerides 22.5 g, refinded olive oil 18.8 gm and fish oil rich in omega-3-acids 11.3 g with 100 gm amino acids,taurine, zinc, electolytes and 42percentage glucose solution with enviornment friendly bag material having t er evident arrows flaps providing 2100 total calories in 1970 ml -1700 non protein energy, new generation 3 chambered bag for parenteral nutrition (iv injection for central line) 986 ml containing combination of smoflipid 20percentage; refined soyabean oil 11.3 g, medium chain triglycerides 11.3 g, refinded olive oil 9.4 gm and fish oil rich in omega-3-acids 5.6 g with 50 g amino acids,taurine, zinc, electolytes and 42percentage glucose solution with enviornment friendly bag material having t er evident arrows flaps providing 1100 total calories in 986 ml - 900 non protein energy, new generation 3 chambered bag for parenteral nutrition (iv injection for peripheral line) 1206 ml containing combination of smoflipid 20percentage; refined soyabean oil 10.2 g, medium chain triglycerides 10.2 g, refinded olive oil 8.5 gm and fish oil rich in omega-3-acids 5.1 g with 38 g amino acids,taurine, zinc, electolytes and 13percentage glucose solution with enviornment friendly bag material having t er evident arrows flaps providing 800 total calories in 1206 ml -700 non protein energy, new generation 3 chambered bag for parenteral nutrition (iv injection for peripheral line) 1448 ml containing combination of smoflipid 20percentage; refined soyabean oil 12.3 g, medium chain triglycerides 12.3 g, refinded olive oil 10.1 g and fish oil rich in omega-3-acids 6.1 g with 46 g amino acids,taurine, zinc, electolytes and 13percentage glucose solution with enviornment friendly bag material having t er evident arrows flaps providing 1000 total calories in 1448 ml -800 non protein energy, new generation 3 chambered bag for parenteral nutrition (iv injection for peripheral line) 1904 ml containing combination of smoflipid 20percentage; refined soyabean oil 16.1 g, medium chain triglycerides 16.1 g, refinded olive oil 13.4 g and fish oil rich in omega-3-acids 8 g with 60 g amino acids,taurine, zinc, electolytes and 13percentage glucose solution with enviornment friendly bag material having t er evident arrows flaps providing 1300 total calories in 1904 ml -1100 non protein energy, new generation 3 chambered bag for parenteral nutrition(iv for centeral line)1477 ml containing combination of smof lipid 20percentage refined soyabean oil 16.9 g, medium chain triglycerides 16.9 g refinded olive oil 14.1g and fish oil rich in omega-3 acids 8.4 g as source of calories with 75 g amino acides,taurine,zinc electrolytes and 42percentage glucose solution with environment friendly bag material having t er evident arrows flaps providing 1600 total calories in 1477 ml- 1300 non protein energy, new generation 3 chambered bag for parenteral nutrition(iv for peripheral line)1448ml containing combination of smof flipid 20percentage refined soyabean oil 12.3g medium chain triglycerides 12.3 g refinded olive oil 10.1g and fish oil rich in omega-3 acids,6.1 g with 46 g amino acids taurine,zinc electrolytes and 13percentage glucose solution with environment friendly bag material having t er evident arrows flaps providing 1000 total calories in 1448 ml- 800 non protein energy, nicardipine1mg/ml, nitroprusside 50mg, non pegylated liposomal doxorubicin - 20mg, nonacog beta pegol,glycopegylated recombinant factor-ix 1000iu, nonacog beta pegol,glycopegylated recombinant factor-ix 1500iu, nonacog beta pegol,glycopegylated recombinant factor-ix 250iu, nonacog beta pegol,glycopegylated recombinant factor-ix 500iu, noradrenaline injection 2 mg/ml , 1 ml , normal saline 0.45percentage, normal saline 3 percentage , 100 ml bottle, ns 3 litre, ns glass bottle 0.9percentage 500 ml, ocrelizumab 300mg/01 ml, octreotide acetate injection 100 mcg, ofloxacin injection 2 mg/ml (for iv infusion), olanzapine 210 mg, olanzapine 300 mg, omalizumab 150 mg, ondansetron injection 2 mg/ml, 4 ml oule, optineuron oule, oxaliplatin injection 2 mg /ml, oxytocin 5 i.u./ml (1 ml oule) (for sc/im/slow iv infusion), paclitaxel injection 300mg, paliperidone 100 mg (for im use), paliperidone 1-palmitate 150 mg, pantoprazole injection 40 mg, paracetamol 1000mg 100ml with manitol in double sterlised within overwrap closed system bag with long temper evedent cap and self sealing port, paracetamol 500mg 50ml with manitol in double sterlised within overwrap closed system bag with long temper evedent cap and self sealing port, paracetamol injection (for iv infusion) 100 ml., paracetamol injection 150 mg/ml (2 ml oule), parenteral lipid emulsion with a combination of 4 different oils in concentrations : 30percentage soyabean oil, 30percentage mct, 25percentage olive oil and 15percentage fish oil with a omega 6: omega 3 ratio of 2.5:1. 100 ml, parenteral lipid emulsion with a combination of 4 different oils in concentrations : 30percentage soyabean oil, 30percentage mct, 25percentage olive oil and 15percentage fish oil with a omega 6: omega 3 ratio of 2.5:1. 250 ml, parenteral lipid emulsion with a combination of 4 different oils in concentrations : 30percentage soyabean oil, 30percentage mct, 25percentage olive oil and 15percentage fish oil with a omega 6: omega 3 ratio of 2.5:1. 500 ml, pcv 13: pneumococcal conjugate vaccine 13 (pneumococcal 13), pegylated recombinant factor viii 1000 iu, pegylated recombinant factor viii 1500 iu, pegylated recombinant factor viii 2000 iu, pegylated recombinant factor viii 250 iu, pegylated recombinant factor viii 500 iu, pemetrexed injection 100 mg, pemetrexed injection 500 mg, pentazocine lactate injection 30 mg/ml (1ml oule) (for sc/im/slow iv use), pheniramine maleate injection 22.75 mg/ml (for im/iv use)., 2 ml oule, phenobarbitone 20 mg/ ml, phenobarbitone 200 mg/ ml, phenoxybenzamine 50mg/ml, phenylephrine hydrochloride 50 mcg / ml, phenytoin sodium injection 50 mg/ml (2 ml oule) (for im/iv use), phytomenadione (vit k1) injection 10 mg/ml , 1ml oule, phytomenadione (vitamin k1) injection 1 mg/0.5 ml (0.5 ml oule), pilocarpine (1 ml oule) (for intracameral use), piperacillin sodium 4 gm and tazobactum sodium 500 mg injection, pipracillin-4000 mg+tazobactum-500 mg+edta-1 mg, plasma dried activated prothrombin complex concentrate (1000 units/vial), pneumococcal polysaccharide vaccine 20 valent ppsv(20), polidocanol injection, polygelin iv preparation (plasma expanding iv fluid) (3.5 percentage infusion solution for iv, sterile and pyrogen free), polymyxin-b sulfate 5 lu, pottasium chloride injection, ppsv (23): pneumococcal polysaccharide vaccine 23, pralidoxime chloride injection 1 gm (im/slowi v/ infusion use), prefilled injection hydroxy propyl methyl, premix human insulin analogue 25:75 100iu/ml in 3 ml, premix human insulin analouge 30:25/70:75 i.e.100 iu/ml in 3 ml., premix human insulin analouge 50:50 100 iu /ml in 3 ml, promethazine hydrochloride injection 25 mg/ml, (2 ml oule), propofol injection 1percentage w/v, 20ml (for iv infusion), propofol with mct lct lead 2 technology and oliec acid 20 ml, propofol with mct lct lead 2 technology and oliec acid 50 ml, protamine sulphate 50mg/ml, quinine dihydrochloride injection 300 mg/ml (2 ml oule) (for slow iv use), rabies human monoclonal antibody 100iu/2.5ml, rabies immunoglobulin human injection 300 iu (2 ml vial), ranibizumab solution for injection 2.3 mg/0.23 ml, ranitidine hydrochloride injection 50 mg/2 ml (2 ml oule) (im/slow iv use), rasburicase injection 1.5 mg, recombinant anti haemophilic factor viii-1000 iu injection, recombinant anti haemophilic factor viii-250 iu vial, recombinant anti haemophilic factor viii-500 iu injection, recombinant anti- d immunoglobuline human 150 mcg vial/pfs injection, recombinant anti- d immunoglobuline human 300 mcg vial/pfs injection, recombinant anti haemophilic factor ix 250 iu, recombinant anti haemophilic factor ix 500 iu, recombinant anti haemophilic factor ix 1000 iu, recombinant anti haemophilic factor ix 250 iu, recombinant anti haemophilic factor vii 1mg (100kiu), recombinant antihemophilic factor viia 2 mg (100 kiu), recombinant insulin glargine (100 iu/ml), remdesivir 100mg/vial, ribavirin 100 mg /ml, ribavirin 200 mg /ml, ringer lactate glass bottle, ringer lactate injection (compound sodium lactate inj.) 500 ml bottle, risdiplam, risperidone 37.5 mg (long acting injection for im use), risperidone 50 mg, rituximab 100 mg, rituximab 500 mg vial, rocuronium bromide 10 mg, romiplastin 125 mg, romiplastin 250 mg, ropivacaine -0.2percentage, ropivacaine -0.5percentage 20 ml, ropivacaine 0.75percentage, 4 ml, ropivacaine 0.75percentage, 20 ml, ropivacaine hydrochloride 7.5 mg + dextrose 80 mg, semagluide rdna 0.25mg, semagluide rdna 0.5mg, semagluide rdna 1.0mg, semagluide rdna 1.7mg, semagluide rdna 2.4mg, sildenafil 10mg, sodium hyaluronate 8 mg, sodium bicarbonate injection 7.5percentage w/v (for iv infusion) 10 ml oule, sodium chloride 0.9percentage w/v and dextrose 5percentage w/v (injection (for i.v.infusion) , 500 ml bottle, sodium chloride and dextrose 0.45percentage, sodium chloride injection 0.9percentage w/v, 500 ml bottle (for iv infusion), sodium chloride injection 0.9 percentage w/v (normal saline) (1000 ml bottle), sodium chloride injection, 0.9percentage w/v, 100 ml bottle, (iv use), sodium hyaluronate (for intracameral use) 1.4 w/v, sodium hyaluronate 8 mg, sodium hyaluronate sterile solution 1percentage, 10mg/ml, sodium valproate injection 100 mg/ml, 5 ml vial, somatrogon 24mg, somatrogon 60mg, somatropin ip (recombinant human growth harmone) - 4iu ( 1.33mg/ml), sovateltide 30µg, sterile vancomycin hcl injection 0.5 gm (slow iv infusion), sterile water 3 litre, sterile water 5 lit, sterile water for injection (5 ml oule), streptokinase injection 1500000 iu (lyophilized powder) (iv infusion), succinyl choline chloride 50 mg/ml (suxamethonium chloride injection), 2 ml oule, suggamadex 100 mg/ml, sulbactum 0.5 gm and cefoperazone 0.5 gm for injection (1 gm), sumatriptan 6mg/0.5ml, teicoplanin 400mg, teicoplanin 600 mg with wf, tenecteplase 20 mg, tenecteplase 40mg/vial, terbutaline 1mg/ml, teriparatide injection 750 mcg/3 ml, terlipressin injection (100 mcg/ml), 10 ml each vial/ oule, testosterone propionate injection 250 mg, tetanus immunoglobulin (human) 250 i.u., tetanus vaccine (adsorbed) human, 0.5 ml oule/vial (for deep im use), thiamine 100 mg/ml, thiamine inj 200 mg/2 ml, thiopentone sodium 0.5 gm. (iv use), three chamber bag of 1400 ml, for total parenteral nutrition containing aminoacids, glucose, fat and total 1000 kcal for peripheral administration. inj., three chamber bag of 2400 ml, for total parenteral nutrition containing aminoacids, glucose, fat and total 1700 kcal for peripheral administration inj., thrombin +fibrin seant 2ml, ticarcillin 3 gm + clavulanic acid 100 mg, tigecycline 50mg/ml, tigecycline inj 100 mg (cake form ), tobramycin 80mg/2ml, torsemide 10 mg/ml, tpn 1500 ml triple chamber bag for central/peripheral vein contains protein 30-60 gm/l lipid 20-40gm/l glucose 80-160 gm/l, tpn 1ltr triple chamber bag for central/peripheral vein contains protein 20-45 gm/l lipid 20-40gm/l glucose 80-160 gm/l, tpn 2000 ml triple chamber bag for central/peripheral vein contains protein 40-85 gm/l lipid 40-80gm/l glucose 160-320 gm/l, tpn solution 1000 ml with amino acids ,glocuse & carbohydartes electrolytes in triple chamber bag(central/peripheral) route, tpn solution 1500 ml with amino acids ,glocuse & carbohydartes electrolytes in triple chamber bag(central/peripheral) route, tpn solution 2000 ml with amino acids ,glocuse & carbohydartes electrolytes in triple chamber bag(central/peripheral) route, trace elements solution for infusion 10 ml contains : zinc 5 mg manganese: 55 micrograms copper: 0.38 mg chromium: 10 micrograms selenium : 79 micrograms fluoride : 0.95 mg iodine : 130 micrograms iron : 1.1mg molybdenum :19 micrograms, tramadol injection 50 mg/ml, (2 ml oule), trenaxamic acid injection 500 mg/5 ml, (5 ml oule)